Skip to content
Stop using now Drug recall · FDA · Published July 10, 2025

Pfizer Bicillin L-A Injectable Suspension Recall: Particulate Risk

Pfizer recalls 1.2 million units of Bicillin L-A (penicillin G benzathine) due to particulates found during visual inspection. Affected products have specific NDC codes and expiration dates. Consumers should contact Pfizer for details.

🇺🇸 FDA recall #D-0544-2025DrugPfizer ›
Take action

Contact the company

Recalling firmPfizer Inc.235 East 42nd Street · New York, NY 10017-5703
✎ GovInfoNow plain-language explainer

Pfizer is recalling 1.2 million units of Bicillin L-A injectable suspension because particulates were found during visual inspection. This could cause serious injury if injected, so affected users should stop using the product and contact Pfizer. Read more at govinfonow.com/recall/31983-pfizer-bicillin-l-a-injectable-suspension-recall-particulate-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/31983-pfizer-bicillin-l-a-injectable-suspension-recall-particulate-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0544-2025

Cite this page

“Pfizer Bicillin L-A Injectable Suspension Recall: Particulate Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/31983-pfizer-bicillin-l-a-injectable-suspension-recall-particulate-risk. Based on FDA recall #D-0544-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0544-2025%22&limit=1).

Pfizer Inc. recalled Bicillin L-A injectable suspension distributed nationwide on July 10, 2025, due to current good manufacturing practice deviations that allowed particulates to enter the product, according to the FDA.

How to tell if you have it

  • Brand: Pfizer
  • Product: Bicillin L-A (penicllin G benzathine injectable suspension)
  • Strength/Size: 1,200,000 units per 2 mL, 2 mL-vial
  • Carton NDC: 60793-701-10
  • Syringe NDC: 60793-701-02
  • Lot codes: HJ3235 (Exp 09/30/26), GL2954, HP6222 (Exp 01/31/27), HR9967 (Exp 05/31/27), HP6232, LT5190 (Exp 09/30/27), HP6228 (Exp 10/31/27)
  • Units affected: 50,855 vials
  • Distribution: Nationwide in the USA

The hazard

The recall addresses current good manufacturing practice deviations where particulates were identified during visual inspection of the injectable suspension.

Context

GovInfoNow's records show Pfizer Inc. has issued 71 other recalls since November 26, 2012. Recent Pfizer recalls include a August 4, 2025 epinephrine vial recall for sterility risks, a May 28, 2025 dobutamine injection recall for discoloration, and a May 20, 2024 labetalol injection recall for incomplete crimp seals. Other recent recalls of similar products include a January 2, 2026 Cipla Lanreotide Injection recall, an August 12, 2026 B. Braun Medical Lactated Ringer's Injection recall, and a March 24, 2026 GE Healthcare Omnipaque 300 mg/mL Injection recall.

How to tell if you have this one

Check for vials labeled 'Bicillin L-A (penicillin G benzathine) 1,200,000 units per 2 mL' with NDC codes 60793-701-10 or 60793-701-02. Products were distributed with specific expiration dates and lots.

  • Brand
    Pfizer
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Nationwide in the USA
  • NDC
    60793-700-01, 60793-700-10, 60793-701-02, 60793-701-10, 60793-702-04, 60793-702-10
Recall numberProduct, codes & lotsQuantity
D-0544-2025Bicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001. Made in Austria, Carton NDC - 60793-701-10, Syringe NDC - 60793-701-02; Lots: HJ3235, Exp 09/30/26; GL2954, HP6222, Exp, 01/31/27; HR9967, Exp 05/31/27; HP6232, LT5190,Exp 09/30/27; HP6228, Exp 10/31/27;50,855 2 mL vials
D-0545-2025Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made in Austria, Carton NDC- 60793-702-10 , Syringe NDC-60793-702-04; Lots GT2598, GT2599, Exp 09/30/26; HK2909, Exp 02/28/27; HR9969, Exp 04/30/27; HR9984, Exp 08/31/27.19,279 vials
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop using the recalled Bicillin L-A vials as they contain particulates that could cause serious injury.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 27 days after the firm started it.

1. Firm started the recall: Jul 10, 202512. FDA classified it Class II: Jul 30, 202523. Published in FDA’s Enforcement Report: Aug 6, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0544-2025 (July 10, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0544-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA